WOLVERINE (20mg)
WOLVERINE | BPC-157 10mg + TB-500 10mg — 20mg | Research Blend | Australia
Wolverine is a research-grade dual peptide blend combining two of the most extensively studied tissue repair compounds in the preclinical literature — BPC-157 and TB-500 — each at 10mg per vial. The two compounds act through complementary but distinct mechanisms, with research suggesting their combined profile covers a broader range of repair and recovery pathways than either compound achieves individually. Available from Austides in research-grade lyophilised form, third-party tested and domestically dispatched from Australia.
BPC-157 (10mg) — Research Applications
Studied extensively in tendon, ligament, muscle, and bone injury models, with researchers observing accelerated healing and improved functional recovery in preclinical settings
Examined in preclinical models for its gastroprotective properties and influence on gastrointestinal mucosal integrity mechanisms
Investigated for its role in modulating pro-inflammatory markers including TNF-α and IL-6 in animal models
Studied for its observed angiogenic activity via VEGFR2 signalling pathways in preclinical research
Examined in models of traumatic brain injury, spinal cord compression, and peripheral nerve damage in preclinical settings
TB-500 (10mg) — Research Applications
Studied in animal models for its effects on wound closure kinetics, with researchers observing accelerated healing outcomes in preclinical settings
Investigated for its primary mechanism involving actin regulation and its influence on repair cell migration to injury sites in preclinical models
Examined for its role in modulating TNF-α, IL-1β, and IL-6 and shifting macrophage activity toward a reparative state in animal research
Studied for its angiogenic activity via VEGF signalling in preclinical models, with researchers examining effects on oxygen and nutrient delivery to damaged tissue
Investigated in heart injury models with researchers examining its effects on inflammation and tissue repair outcomes in preclinical settings
Product Specifications
BPC-157 | 15 amino acids · ~1,419 Da |
TB-500 | 7 amino acids (Ac-LKKTETQ) · ~889 Da |
Total Blend | 20mg per vial |
Form | Lyophilised powder |
Purity | ≥99% (HPLC verified) |
Storage | Store at -20°C, away from light. Stable 24 months unopened. |
Austides Standard
All Austides peptides are third-party tested for purity and potency. Domestically dispatched from Australia with discrete, secure packaging and cold-chain integrity maintained throughout.
For research purposes only. Not for human consumption, therapeutic use, or self-administration. This product is not approved by the TGA for any therapeutic application.
){kind=link}